Study finds immune cells in glioblastoma use fructose to evade immune response, pointing to a new treatment target

Every year, millions of people are diagnosed with cancer globally; however, current treatments are limited by disease complexity. A study published in the open-access journal in PLOS Biology by Tianyu Jiang at Shandong University, Qingdao, China and colleagues suggests that Escherichia coli Nissle 1917 (EcN) may be engineered with anticancer agents to treat cancerous tumors in mice.

A new study, published in Nature, outlines a method combining smartwatches and routine blood tests to better detect insulin resistance in its early stages, and its early validation testing has shown good accuracy.